Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
Go back to Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program| (NASDAQ: TRVI) | Delayed: 13.30 +0.22 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.08 | 52 Week High | $ | |||
| Open | $12.82 | 52 Week Low | $ | |||
| Day High | $13.55 | P/E | N/A | |||
| Day Low | $12.76 | EPS | $ | |||
| Volume | 1,113,614 | |||||
